title: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis.
abstract: BACKGROUND
  Respiratory syncytial virus (RSV) bronchiolitis in infants is characterized by a massive neutrophilic infiltrate into the airways. Chemokines direct migration of leukocytes and contribute to the pathogenesis of RSV disease. However, little is known about pulmonary chemokine responses to RSV in humans. Our aim was to characterize the production of chemokines in the lungs of infants with RSV bronchiolitis and how this production changes over time.
  
  
  METHODS
  Chemokine mRNA and the concentration of chemokines were measured in nonbronchoscopic bronchoalveolar lavage (BAL) samples from infants with RSV bronchiolitis and from control infants. In infants with RSV bronchiolitis, changes in the concentrations of chemokines during the 7 days after intubation and between the days of intubation and extubation were examined.
  
  
  RESULTS
  The production of chemokines within the lower respiratory tract was shown in all patients with RSV bronchiolitis. CXC chemokines (particularly CXCL10/interferon-inducible protein 10 and CXCL8/interleukin-8) were found to be the most abundant, but CC chemokines (CCL2/monocyte chemotactic protein 1 and CCL3/macrophage inflammatory protein-1 alpha) were also present. Concentrations of some of these chemokines remained elevated over the course of the illness, whereas others decreased steadily. No differences in the concentrations were found between the days of intubation and extubation.
  
  
  CONCLUSIONS
  CXC chemokines predominate within the RSV-infected lung. Much of this response comes from inflammatory cells within the lower respiratory tract. Chemokine response patterns vary over time, possibly indicating different cellular sources for individual chemokines in the RSV-infected lung.
authors.affiliation: Department of Child Health, Institute of Child Health, Alder Hey Children's Hospital, University of Liverpool, Liverpool, United Kingdom. mcnamp@liv.ac.uk
authors.forename: Paul S
authors.initials: PS
authors.lastname: McNamara
authors.forename: Brian F
authors.initials: BF
authors.lastname: Flanagan
authors.forename: C Anthony
authors.initials: CA
authors.lastname: Hart
authors.forename: Rosalind L
authors.initials: RL
authors.lastname: Smyth
mesh_terms: D001988:Bronchiolitis / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D018893:Bronchoalveolar Lavage; D018925:Chemokines / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D005260:Female; D024581:Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) / Q000235:genetics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008168:Lung / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008297:Male; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D018357:Respiratory Syncytial Virus Infections / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D013997:Time Factors
chemical_list: D018925:Chemokines; D012333:RNA, Messenger; D024581:Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)